Q: How serious is chronic myelogenous leukemia (CML)?

Chronic myelogenous leukemia (CML) is a serious condition , but it usually develops slowly. Most types of cancer are given a stage to show how much the cancer has spread. However, CML is different. Instead of stages, CML is divided into 3 phases. The phase of CML depends mostly on the number of immature white blood cells – called blasts – in the blood or bone marrow. According to the American Cancer Society , the phases, from less serious to more serious, are: Chronic phase – Most of the time, CML is in the chronic phase when it’s first found. Most people have mild symptoms or none. Treatment usually works well during this early phase. Accelerated phase – Symptoms become more noticeable in this phase. The number of blasts in the blood or bone marrow increases, and treatment may need to be adjusted. Blast phase – Also called acute phase or blast crisis, this phase can cause serious infections, bleeding, and anemia, which is when the body doesn’t have enough healthy red blood cells to carry oxygen.

Question 1

What are the symptoms of chronic myelogenous leukemia (CML)?

Accepted Answer

The symptoms of chronic myelogenous leukemia (CML) can vary from person to person. Some people might not notice any symptoms at first. When symptoms do appear, they can include: Fatigue Unexplained weight loss Night sweats A feeling of fullness or discomfort under the left ribcage (due to an enlarged spleen) Fever Bone pain Frequent infections

Question 2

How serious is chronic myelogenous leukemia (CML)?

Accepted Answer

Chronic myelogenous leukemia (CML) is a serious condition, but it usually develops slowly. Most types of cancer are given a stage to show how much the cancer has spread. However, CML is different. Instead of stages, CML is divided into 3 phases. The phase of CML depends mostly on the number of immature white blood cells – called blasts – in the blood or bone marrow.

According to the American Cancer Society, the phases, from less serious to more serious, are:

Chronic phase – Most of the time, CML is in the chronic phase when it’s first found. Most people have mild symptoms or none. Treatment usually works well during this early phase.

Accelerated phase – Symptoms become more noticeable in this phase. The number of blasts in the blood or bone marrow increases, and treatment may need to be adjusted.

Blast phase – Also called acute phase or blast crisis, this phase can cause serious infections, bleeding, and anemia, which is when the body doesn’t have enough healthy red blood cells to carry oxygen.

Question 3

Is chronic myelogenous leukemia (CML) considered a terminal illness?

Accepted Answer

Chronic myelogenous leukemia (CML) is not always considered terminal (deadly). Thanks to new treatments, many people with CML can have normal life spans and high survival rates. Some people even reach remission, where cancer is no longer detectable in the body. However, CML is a chronic (lifelong) condition that requires long-term treatment and careful monitoring.

Question 4

What treatments are available for chronic myelogenous leukemia (CML)?

Accepted Answer

There are several treatments available for chronic myelogenous leukemia (CML). The most common treatment is a type of medicine called a tyrosine kinase inhibitor (TKI), which targets the cancer cells and stops them from growing. Other treatments might include chemotherapy, stem cell or bone marrow transplants, or participating in clinical trials. The treatment plan usually depends on the CML phase and the patient’s overall health.

Question 5

When should I see a Chronic Myelogenous Leukemia (CML) doctor in Canada?

Accepted Answer

There are various reasons why you may want to see a specialist, such as:

Your primary care provider recommends it.

Your condition requires expert knowledge and specialized care.

Your symptoms persist or worsen despite treatment.

You need specialized testing or procedures.

You want a second opinion.

Question 6

What should I consider when choosing a Chronic Myelogenous Leukemia (CML) doctor in Canada?

Accepted Answer

It’s important to see a provider with expertise in your specific condition. Each provider profile in MediFind’s doctor database includes information on which conditions they treat, years of experience, research contributions, languages spoken, insurance plans accepted, and more.

Question 7

How do I find the best Chronic Myelogenous Leukemia (CML) doctor in Canada?

Accepted Answer

You can find a Chronic Myelogenous Leukemia (CML) doctor in any of the 10 largest U.S. cities by clicking below:

Question 8

How does MediFind rank Chronic Myelogenous Leukemia (CML) doctors in Canada?

Accepted Answer

MediFind’s rankings are based on a variety of data sources, such as the number of articles a doctor has published in medical journals, participation in clinical trials and industry conferences, as well as the number of patients that provider sees for a given condition. Note that MediFind’s provider database is not based on user reviews, and providers do not pay to be included in the database.

Question 9

What types of insurance are accepted by Chronic Myelogenous Leukemia (CML) doctors in Canada?

Accepted Answer

Most profiles in MediFind’s doctor database include a list of insurance plans accepted by that provider. However, it’s a good idea to contact the provider’s office to make sure they still accept your insurance, then doublecheck by contacting your insurance plan to confirm they’re in network.

Question 10

How can I book an appointment online with a Chronic Myelogenous Leukemia (CML) doctor in Canada?

Accepted Answer

MediFind offers direct scheduling for certain providers using the “Request Appointment” button on that provider’s profile. If the schedule option is not available for a provider, tap the red “Show Phone Number” button on their profile to get their contact information. If you prefer to find providers who offer online scheduling, select “Schedules online” under the “Availability” category of the filter feature on the left side of the Chronic Myelogenous Leukemia (CML) doctor search results page.

Question 11

Why is it important to get a second opinion from a different Chronic Myelogenous Leukemia (CML) doctor?

Accepted Answer

Second opinions are an opportunity to confirm a diagnosis and its root cause, learn about alternative treatment options, or simply gain peace of mind. Many people, especially those with serious diagnoses, get second opinions so they can understand all their options and make informed decisions, so don’t hesitate to get one if you have any doubts or need more information or clarification regarding your care. Note that some insurance plans require second opinions, while others don’t cover second opinions, so be sure to confirm with your insurance provider first.

Question 12

How can I prepare for my appointment with a Chronic Myelogenous Leukemia (CML) doctor in Canada?

Accepted Answer

Prepare for your appointment by gathering the following items:

Copies of medical records (dating back at least one year)

Your medical history, including illnesses, medical conditions, surgeries, and other doctors you see

Family history of disease

List of current prescription drugs, over-the-counter medicines, vitamins, and herbal remedies or supplements including names and doses

Allergies to medications, food, latex, insects, etc.

List of questions and concerns

Your insurance card

You might also contact the provider’s office to see if they offer transportation or childcare services or if you’re allowed to bring a loved one for support or to take notes during your visit.

Question 13

What questions should I ask my Chronic Myelogenous Leukemia (CML) doctor?

Accepted Answer

Here are some sample questions:

Can you explain in simple terms what this condition is and how it’s treated?

What symptoms or side effects should I watch for?

What tests will be involved, and when can I expect results?

Are there other specialists I need to see?

What’s the best way to reach you if I have follow-up questions?

Question 14

How can I learn about the latest clinical trials and research advances my Chronic Myelogenous Leukemia (CML) doctor may know about ?

Accepted Answer

MediFind’s Clinical Trials tool asks you a series of questions to help you narrow down your search by health condition, age, gender, location, how far you’re willing to travel, and more. Each question you answer filters down the number of trials until you find the ones that are most relevant to you.

MediFind’s Latest Advances tool features summaries of recent articles published in medical journals. We use cutting-edge technology to scour medical publication databases for the latest research advancements on any given condition, then we simplify this information in a way that’s useful and easy to understand.

Question 15

Can I filter my search to show male or female Chronic Myelogenous Leukemia (CML) doctors in Canada?

Accepted Answer

Look for the filter feature on the left side of the Chronic Myelogenous Leukemia (CML) doctor search results page. Select “Female” or “Male” under the “Gender” category to search for female or male providers exclusively. If the “Any” option is selected, it will pull results for both male and female providers.

Question 16

Can I filter my search to find a Chronic Myelogenous Leukemia (CML) doctor that offers video calls ?

Accepted Answer

Look for the filter feature on the left-side of the Chronic Myelogenous Leukemia (CML) doctor search results page. Select “Offers telehealth visits” under the Availability category to search for providers who offer virtual appointments (video calls).

The 20 Best Chronic Myelogenous Leukemia (CML) Doctors in Canada

Find the Top Chronic Myelogenous Leukemia (CML) Experts and Specialists

Jeffrey H. Lipton

Jeffrey H. Lipton

Dominick Viau-Latremouille

Dominick Viau-Latremouille

Sarit E. Assouline

Sarit E. Assouline

Xiaoyan Jiang

Xiaoyan Jiang

Donna L. Forrest

Donna L. Forrest

Lambert Busque

Lambert Busque

Connie J. Eaves

Connie J. Eaves

Brian Leber

Brian Leber

Kirk R. Schultz

Kirk R. Schultz

Josephine T. Tauer

Josephine T. Tauer

Mark D. Minden

Mark D. Minden

Jeff H. Lipton

Jeff H. Lipton

Katharina Rothe

Katharina Rothe

Maria A. Perusini